GFPT1 and cardiac hypertrophy: More recently, Gelinas et al.25 showed that 5′-adenosine monophosphate-activated protein kinase (AMPK) prevents pathological cardiac hypertrophy by promoting Gfat1 phosphorylation and thereby decreasing O-GlcNAc modification in the heart.